Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Wallace

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Human Vaccines & Immunotherapeutics|September 22, 2017
Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccinesShixia Wang, Te-Hui Chou, Anthony Hackett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 30, 2018
Human Anti-HIV-1 gp120 Monoclonal Antibodies with Neutralizing Activity Cloned from Humanized Mice Infected with HIV-1Melissa A Gawron, Mark Duval, Claudia Carbone, et al.
Vaccine|May 28, 2021
A systems map of the economic considerations for vaccination: Application to hard-to-reach populationsSarah N Cox, Patrick T Wedlock, Sarah W Pallas, et al.
Vaccines|January 8, 2025
Evaluation of Integrated Child Health Days as a Catch-Up Strategy for Immunization in Three Districts in UgandaMansoor Farahani, Tonny Tindyebwa, Nandita Sugandhi, et al.
Vaccine|November 16, 2018
Introduction of inactivated poliovirus vaccine in the Philippines: Effect on health care provider and infant caregiver attitudes and practicesAnna Lena Lopez, Jennifer B Harris, Peter Francis Raguindin, et al.
Journal of Virology|November 10, 2017
HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is OccludedBriana Quitadamo, Paul J Peters, Alexander Repik, et al.
The Journal of Infectious Diseases|February 9, 2012
Community and health worker perceptions and preferences regarding integration of other health services with routine vaccinations: four case studiesTove K Ryman, Aaron Wallace, Richard Mihigo, et al.
Journal of Virology|October 12, 2012
Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropismOlivia O'Connell, Alexander Repik, Jacqueline D Reeves, et al.
Nature Microbiology|August 22, 2024
Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosisEdward B Irvine, Angel Nikolov, Mehak Z Khan, et al.
Vaccines|July 27, 2024
Qualitative Insights on Barriers to Receiving a Second Dose of Measles-Containing Vaccine (MCV2), Oromia Region of EthiopiaKalkidan Solomon, Brooke N Aksnes, Abyot Bekele Woyessa, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Human Vaccines & Immunotherapeutics|September 22, 2017
Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccinesShixia Wang, Te-Hui Chou, Anthony Hackett, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 30, 2018
Human Anti-HIV-1 gp120 Monoclonal Antibodies with Neutralizing Activity Cloned from Humanized Mice Infected with HIV-1Melissa A Gawron, Mark Duval, Claudia Carbone, et al.
Vaccine|May 28, 2021
A systems map of the economic considerations for vaccination: Application to hard-to-reach populationsSarah N Cox, Patrick T Wedlock, Sarah W Pallas, et al.
Vaccines|January 8, 2025
Evaluation of Integrated Child Health Days as a Catch-Up Strategy for Immunization in Three Districts in UgandaMansoor Farahani, Tonny Tindyebwa, Nandita Sugandhi, et al.
Vaccine|November 16, 2018
Introduction of inactivated poliovirus vaccine in the Philippines: Effect on health care provider and infant caregiver attitudes and practicesAnna Lena Lopez, Jennifer B Harris, Peter Francis Raguindin, et al.
Journal of Virology|November 10, 2017
HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is OccludedBriana Quitadamo, Paul J Peters, Alexander Repik, et al.
The Journal of Infectious Diseases|February 9, 2012
Community and health worker perceptions and preferences regarding integration of other health services with routine vaccinations: four case studiesTove K Ryman, Aaron Wallace, Richard Mihigo, et al.
Journal of Virology|October 12, 2012
Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropismOlivia O'Connell, Alexander Repik, Jacqueline D Reeves, et al.
Nature Microbiology|August 22, 2024
Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosisEdward B Irvine, Angel Nikolov, Mehak Z Khan, et al.
Vaccines|July 27, 2024
Qualitative Insights on Barriers to Receiving a Second Dose of Measles-Containing Vaccine (MCV2), Oromia Region of EthiopiaKalkidan Solomon, Brooke N Aksnes, Abyot Bekele Woyessa, et al.
Pageof 5